IP Library Granted Patent US 12,575,017
Granted Patent B2
US 12,575,017 · App. 18/749,281 · Granted Mar 10, 2026

Systems, methods, and devices for generating predominantly radially expanded plasma flow

Inventor: Nikolay Suslov (Roswell, GA)
Assignee: Plasma Surgical, Inc.
H05H1/46H05H1/02H05H1/54H05H2242/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,575,017
App. No.
18/749,281
Granted
Mar 10, 2026
Kind
B2
Abstract

Systems, devices, and methods generating a plasma flow are disclosed. A method may include applying energy that alternates between being at a base level for a first duration and at a pulse level for a second duration according to a controlled pattern, generating a plasma flow having a directional axis, and discharging the plasma flow alternating between a base configuration and a pulse configuration according to the controlled pattern. The plasma flow in the base configuration may have (1) a first temperature at the outlet and (2) a first flow front that advances along the directional axis. The plasma flow in the pulse configuration may have (1) a second temperature at the outlet that is greater than the first temperature and (2) a second flow front that advances along the directional axis at a speed greater than the first flow front.

Claims (45)

1 . A plasma generating device, comprising:

an active chamber having an inlet;

a gas inlet configured to supply a gas flow to the active chamber, the gas flow having adjustable parameters;

an anode and a cathode configured to establish an electric arc in the active chamber to generate a plasma flow from the gas flow; and

an outlet configured to discharge the gas flow or the plasma flow according to a predetermined sequence to control heating of a portion of tissue by:

discharging, during a first period of time and when the electric arc is established, the plasma flow with a first energy flux to treat the portion of tissue; and

discharging, during a second period of time and after at least one of the adjustable parameters of the gas flow is adjusted, the gas flow or the plasma flow with a second energy flux lower than the first energy flux.

2 . The plasma generating device of claim 1 , wherein during the first period of time, the plasma flow discharged has a first shape with a first active zone,

during the second period of time, the plasma flow is discharged having a second shape with a second active zone smaller than the first active zone.

3 . The plasma generating device of claim 1 , wherein discharging the plasma flow during the first period of time predominantly causes vaporization of liquid from the portion of tissue, discharging the plasma flow during the second period of time predominantly causes heat diffusion inside the portion of tissue.

4 . The plasma generating device of claim 1 , wherein at least one of the adjustable parameters of the gas flow includes a flow rate of the gas flow.

5 . The plasma generating device of claim 4 , wherein the flow rate of the gas flow is higher during the first period of time than the second period of time to cause the first energy flux to be higher than the second energy flux.

6 . The plasma generating device of claim 4 , wherein a ratio of the flow rate of the gas flow to a diameter of the outlet is less than or equal to 100.

7 . The plasma generating device of claim 1 , wherein the plasma flow discharged during the first period of time has a first temperature and the plasma flow discharged during the second period of time has a second temperature, the first temperature is no greater than 20,000 K and the second temperature is no greater than 10,000 K.

8 . A plasma generating device, comprising:

an active chamber having an inlet;

a gas inlet configured to supply a gas flow to the active chamber;

an anode and a cathode configured to establish an electric arc in the active chamber in response to being energized by current having a controlled pattern to generate a plasma flow from the gas flow; and

an outlet configured to discharge the plasma flow to control heating of a portion of tissue by:

discharging, during a first period of time, the plasma flow with a first shape to treat a portion of tissue, the first shape having a first active zone; and

discharging, during a second period of time and after adjusting the controlled pattern of the current, the plasma flow with a second shape, the second shape having a second active zone smaller than the first active zone.

9 . The plasma generating device of claim 8 , wherein the plasma generating device is configured to adjust one or more parameters of the gas flow to adjust an energy flux of the plasma flow discharged from the outlet.

10 . The plasma generating device of claim 8 , wherein the plasma flow discharged during the first period of time has a first energy flux and the plasma flow discharged during the second period of time has a second energy flux lower than the first energy flux.

11 . The plasma generating device of claim 9 , wherein at least one of the adjustable parameters of the gas flow includes a flow rate of the gas flow, a ratio of the flow rate of the gas flow to a diameter of the outlet is less than or equal to 100.

12 . The plasma generating device of claim 8 , wherein during the first period of time, the plasma generating device is configured to generate a current pattern between the anode and the cathode such the electric arc heats the gas flow with a predetermined temperature profile, the current pattern including oscillations between a base level and a pulse level.

13 . The plasma generating device of claim 12 , wherein the current pattern is a first current pattern including oscillations between a first base level and a first pulse level, and the predetermined temperature profile is a first predetermined temperature profile,

during the second period of time, the plasma generating device is configured to generate a second current pattern between the anode and the cathode such that the electric arc heats the gas flow with a second predetermined temperature profile, the second current pattern including oscillations between a second base level lower than the first base level and a second pulse level lower than the first pulse level.

14 . A method, comprising:

generating a first current pattern configured to generate a first plasma flow from a plasma generating device having a first energy flux and a predetermined shape, the first current pattern including oscillations between a first base level and first pulse level;

applying the first plasma flow from the plasma generating device to the tissue;

generating a second current pattern to generate a second plasma flow from the plasma generating device having a second energy flux lower than the first energy flux, the second current pattern including oscillations between a second base level and a second pulse level, the second base level lower than the first base level and the second pulse level lower than the first pulse level; and

applying the second plasma flow from the plasma generating device to the tissue.

15 . The method of claim 14 , wherein the predetermined shape is a first predetermined shape with a first active zone, wherein the second plasma flow has a second predetermined shape with a second active zone smaller than the first active zone.

16 . The method of claim 14 , wherein the first current pattern causes the first plasma flow to alternate between a first base temperature and a first pulse temperature, and the second current pattern causes the second plasma flow to alternate between a second base temperature and a second pulse temperature.

17 . The method of claim 14 , wherein the first current pattern includes oscillations having a current pulse resolution between 0.1 ms to about 0.2 ms, the second current pattern includes oscillations having a current pulse resolution between about 0.1 microseconds (μs) and about 1 μs.

18 . The method of claim 14 , wherein a root mean square of current having at least one of the first current pattern or the second current pattern is about 12 Amps (A) to about 15 A.

19 . The method of claim 14 , wherein the applying the first plasma flow from the plasma generating device causes at least one of (i) coagulation of the tissue or (ii) vaporization of the tissue without heat diffusion, and applying the second plasma flow from the plasma generating device controls an amount of heat diffusion inside the tissue.

20 . A method, comprising:

generating a first current pattern configured to generate a first output from a plasma generating device having a first energy flux and a predetermined shape, the first current pattern including oscillations between a first set of current levels,

applying the first output from the plasma generating device to tissue to cause coagulation of the tissue;

generating a second current pattern configured to generate a second output from the plasma generating device having a second energy flux lower than the first energy flux; and

applying the second output from the plasma generating device to the tissue to prevent overheating of the tissue.

21 . The method of claim 20 , wherein the first output from the plasma generating device is a plasma flow and the second output is a gas flow.

22 . The method of claim 20 , wherein the first output is a first plasma flow and the second output is a second plasma flow, the first current pattern causes the first plasma flow to alternate between a first base temperature and a first pulse temperature, and the second current pattern causes the second plasma flow to alternate between a second base temperature and a second pulse temperature.

23 . The method of claim 20 , wherein a root mean square of current having at least one of the first current pattern or the second current pattern is about 12 Amps (A) to about 15 A.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2025
From: PLASMA SURGICAL INVESTMENTS LIMITED
To: PLASMA SURGICAL, INC.
Reel/Frame 070148/0190 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2025
From: SUSLOV, NIKOLAY
To: PLASMA SURGICAL INVESTMENTS LIMITED
Reel/Frame 070148/0441 →
Continuity (5)
Continuation 18538270 · Dec 13, 2023
Continuation 18114023 · Feb 24, 2023
Continuation PCTUS2021048052 · Aug 27, 2021
Provisional Application 63071787 · Aug 28, 2020
Related Publication 20250159791A1 · May 15, 2025
References Cited (400)
US 3077108A · Gage et al. · 1963 [cited by applicant]
US 3082314A · Yoshiaki et al. · 1963 [cited by applicant]
US 3100489A · Bagley · 1963 [cited by applicant]
US 3145287A · Siebein et al. · 1964 [cited by applicant]
US 3153133A · Ducati · 1964 [cited by applicant]
US 3270745A · Wood · 1966 [cited by applicant]
US 3360988A · Stine et al. · 1968 [cited by applicant]
US 3396882A · Abe · 1968 [cited by applicant]
US 3413509A · Cann et al. · 1968 [cited by applicant]
US 3433991A · Whyman · 1969 [cited by applicant]
US 3434476A · Shaw · 1969 [cited by examiner]
US 3534388A · Ito et al. · 1970 [cited by applicant]
US 3534739A · Bryne · 1970 [cited by examiner]
US 3628079A · Dobbs et al. · 1971 [cited by applicant]
US 3676638A · Stand · 1972 [cited by applicant]
US 3775825A · Wood · 1973 [cited by applicant]
US 3803380A · Ragaller · 1974 [cited by applicant]
US 3838242A · Goucher · 1974 [cited by applicant]
US 3851140A · Coucher · 1974 [cited by applicant]
US 3866089A · Hengartner · 1975 [cited by applicant]
US 3903891A · Brayshaw · 1975 [cited by applicant]
US 3914573A · Muehlberger · 1975 [cited by applicant]
US 3938525A · Coucher · 1976 [cited by applicant]
US 3991764A · Incropera et al. · 1976 [cited by applicant]
US 3995138A · Kalev et al. · 1976 [cited by applicant]
US 4029930A · Sagara et al. · 1977 [cited by applicant]
US 4035684A · Svoboda et al. · 1977 [cited by applicant]
US 4041952A · Morrison, Jr. et al. · 1977 [cited by applicant]
US 4201314A · Samuels et al. · 1980 [cited by applicant]
US 4256779A · Sokol et al. · 1981 [cited by applicant]
US 4317984A · Fridlyand · 1982 [cited by applicant]
US 4397312A · Molko · 1983 [cited by applicant]
US 4445021A · Irons et al. · 1984 [cited by applicant]
US 4620080A · Arata et al. · 1986 [cited by applicant]
US 4661682A · Gruner et al. · 1987 [cited by applicant]
US 4672163A · Matsui et al. · 1987 [cited by applicant]
US 4674683A · Fabel · 1987 [cited by applicant]
US 4682598A · Beraha · 1987 [cited by applicant]
US 4696855A · Pettit, Jr. et al. · 1987 [cited by applicant]
US 4711627A · Oeschsle et al. · 1987 [cited by applicant]
US 4713170A · Saibic · 1987 [cited by applicant]
US 4743734A · Garlanov et al. · 1988 [cited by applicant]
US 4764656A · Browning · 1988 [cited by applicant]
US 4777949A · Perlin · 1988 [cited by applicant]
US 4780591A · Bernecki et al. · 1988 [cited by applicant]
US 4781175A · McGreevy et al. · 1988 [cited by applicant]
US 4784321A · Delaplace · 1988 [cited by applicant]
US 4785220A · Brown et al. · 1988 [cited by applicant]
US 4839492A · Bouchier et al. · 1989 [cited by applicant]
US 4841114A · Browning · 1989 [cited by applicant]
US 4853515A · Willen et al. · 1989 [cited by applicant]
US 4855563A · Beresnev et al. · 1989 [cited by applicant]
US 4866240A · Webber · 1989 [cited by applicant]
US 4869936A · Moskowitz et al. · 1989 [cited by applicant]
US 4874988A · English et al. · 1989 [cited by applicant]
US 4877937A · Mueller · 1989 [cited by applicant]
US 4902871A · Sanders · 1990 [cited by examiner]
US 4916273A · Browning · 1990 [cited by applicant]
US 4924059A · Rotolico et al. · 1990 [cited by applicant]
US 5008511A · Ross · 1991 [cited by applicant]
US 5013883A · Fuimefreddo et al. · 1991 [cited by applicant]
US 5045667A · Iceland · 1991 [cited by examiner]
US 5079403A · Sturges et al. · 1992 [cited by applicant]
US 5100402A · Fan · 1992 [cited by applicant]
US 5144110A · Marantz et al. · 1992 [cited by applicant]
US 5151102A · Kamiyama et al. · 1992 [cited by applicant]
US 5155547A · Casper · 1992 [cited by examiner]
US 5183990A · Enyedy · 1993 [cited by examiner]
US 5201900A · Nardella · 1993 [cited by applicant]
US 5207691A · Nardella · 1993 [cited by applicant]
US 5211646A · Alperovich et al. · 1993 [cited by applicant]
US 5217460A · Knoepfler · 1993 [cited by applicant]
US 5225652A · Landes · 1993 [cited by applicant]
US 5227603A · Doolette et al. · 1993 [cited by applicant]
US 5261905A · Dorsey, III · 1993 [cited by applicant]
US 5285967A · Weidman · 1994 [cited by applicant]
US 5330606A · Kubota · 1994 [cited by examiner]
US 5332885A · Landes · 1994 [cited by applicant]
US 5352219A · Reddy · 1994 [cited by applicant]
US 5403312A · Yates et al. · 1995 [cited by applicant]
US 5406046A · Landes · 1995 [cited by applicant]
US 5408066A · Trapani et al. · 1995 [cited by applicant]
US 5412173A · Muehlberger · 1995 [cited by applicant]
US 5445638A · Rydell et al. · 1995 [cited by applicant]
US 5452854A · Keller · 1995 [cited by applicant]
US 5460629A · Shlain et al. · 1995 [cited by applicant]
US 5485721A · Steenborg · 1996 [cited by applicant]
US 5514848A · Ross et al. · 1996 [cited by applicant]
US 5519183A · Mueller · 1996 [cited by applicant]
US 5527313A · Scott et al. · 1996 [cited by applicant]
US 5571366A · Ishii · 1996 [cited by examiner]
US 5573682A · Beason, Jr. et al. · 1996 [cited by applicant]
US 5582611A · Tsuruta et al. · 1996 [cited by applicant]
US 5620616A · Anderson et al. · 1997 [cited by applicant]
US 5629585A · Altmann et al. · 1997 [cited by applicant]
US 5637242A · Muehlberger · 1997 [cited by applicant]
US 5640843A · Aston · 1997 [cited by applicant]
US 5662680A · Desai · 1997 [cited by applicant]
US 5665085A · Nardella · 1997 [cited by applicant]
US 5679167A · Muehlberger · 1997 [cited by applicant]
US 5680014A · Miyamoto et al. · 1997 [cited by applicant]
US 5688270A · Yates et al. · 1997 [cited by applicant]
US 5697281A · Eggers et al. · 1997 [cited by applicant]
US 5697882A · Eggers et al. · 1997 [cited by applicant]
US 5702390A · Austin et al. · 1997 [cited by applicant]
US 5720745A · Farin et al. · 1998 [cited by applicant]
US 5733662A · Bogachek · 1998 [cited by applicant]
US 5797941A · Schulze et al. · 1998 [cited by applicant]
US 5827271A · Buysse et al. · 1998 [cited by applicant]
US 5833690A · Yates et al. · 1998 [cited by applicant]
US 5837959A · Muehlberger et al. · 1998 [cited by applicant]
US 5843079A · Suslov · 1998 [cited by applicant]
US 5858469A · Sahoo et al. · 1999 [cited by applicant]
US 5858470A · Bernecki et al. · 1999 [cited by applicant]
US 5897059A · Mueller · 1999 [cited by applicant]
US 5906757A · Kong et al. · 1999 [cited by applicant]
US 5932293A · Belashchenko et al. · 1999 [cited by applicant]
US 6033788A · Cawley et al. · 2000 [cited by applicant]
US 6042019A · Rusch · 2000 [cited by applicant]
US 6099523A · Kim et al. · 2000 [cited by applicant]
US 6114649A · Delcea · 2000 [cited by applicant]
US 6135998A · Palanker · 2000 [cited by applicant]
US 6137078A · Keller · 2000 [cited by applicant]
US 6137231A · Anders et al. · 2000 [cited by applicant]
US 6162220A · Nezhat · 2000 [cited by applicant]
US 6169370B1 · Platzer · 2001 [cited by applicant]
US 6181053B1 · Roberts · 2001 [cited by applicant]
US 6202939B1 · Delcea · 2001 [cited by applicant]
US 6209878B1 · Munro · 2001 [cited by applicant]
US 6273789B1 · LaSalle et al. · 2001 [cited by applicant]
US 6283386B1 · Van Steenkiste et al. · 2001 [cited by applicant]
US 6329628B1 · Kuo et al. · 2001 [cited by applicant]
US 6352533B1 · Ellman et al. · 2002 [cited by applicant]
US 6386140B1 · Müller et al. · 2002 [cited by applicant]
US 6392189B1 · Delcea · 2002 [cited by applicant]
US 6443948B1 · Suslov · 2002 [cited by applicant]
US 6475215B1 · Tanrisever · 2002 [cited by applicant]
US 6514252B2 · Nezhat et al. · 2003 [cited by applicant]
US 6515252B1 · Girold · 2003 [cited by applicant]
US 6528947B1 · Chen et al. · 2003 [cited by applicant]
US 6548817B1 · Anders et al. · 2003 [cited by applicant]
US 6558383B2 · Cunningham et al. · 2003 [cited by applicant]
US 6562037B2 · Paton et al. · 2003 [cited by applicant]
US 6629974B2 · Penny et al. · 2003 [cited by applicant]
US 6657152B2 · Shimazu · 2003 [cited by applicant]
US 6669106B2 · Delcea · 2003 [cited by applicant]
US 6676655B2 · McDaniel · 2004 [cited by applicant]
US 6780184B2 · Tanrisever · 2004 [cited by applicant]
US 6845929B2 · Dolatabadi et al. · 2005 [cited by applicant]
US 6886757B2 · Byrnes et al. · 2005 [cited by applicant]
US 6958063B1 · Soll et al. · 2005 [cited by applicant]
US 6972138B2 · Heinrich et al. · 2005 [cited by applicant]
US 6986471B1 · Kowalsky et al. · 2006 [cited by applicant]
US 7025764B2 · Paton et al. · 2006 [cited by applicant]
US 7030336B1 · Hawley · 2006 [cited by applicant]
US 7118570B2 · Tetzlaff et al. · 2006 [cited by applicant]
US 7223676B2 · Hanawa · 2007 [cited by examiner]
US 7361175B2 · Suslov · 2008 [cited by examiner]
US 7589473B2 · Suslov · 2009 [cited by applicant]
US 8030849B2 · Suslov · 2011 [cited by examiner]
US 8043286B2 · Palanker et al. · 2011 [cited by applicant]
US 8105325B2 · Suslov · 2012 [cited by examiner]
US 8226644B2 · Sartor et al. · 2012 [cited by applicant]
US 8465487B2 · Suslov · 2013 [cited by examiner]
US 8613742B2 · Suslov · 2013 [cited by examiner]
US 8735766B2 · Suslov · 2014 [cited by examiner]
US 8876746B2 · Davison · 2014 [cited by examiner]
US 9089319B2 · Suslov · 2015 [cited by examiner]
US 9168087B2 · Davison · 2015 [cited by examiner]
US 9254167B2 · Davison · 2016 [cited by examiner]
US 9640368B2 · Umehara · 2017 [cited by examiner]
US 9801678B2 · Cox · 2017 [cited by examiner]
US 9913358B2 · Suslov · 2018 [cited by examiner]
US 10201067B2 · Suslov · 2019 [cited by examiner]
US 10463418B2 · Suslov · 2019 [cited by examiner]
US 10492845B2 · Suslov · 2019 [cited by examiner]
US 10631911B2 · Suslov · 2020 [cited by examiner]
US 10648728B2 · Piel · 2020 [cited by examiner]
US 10991554B2 · Zhao · 2021 [cited by examiner]
US 11232931B2 · Huh · 2022 [cited by examiner]
US 11621587B1 · Yanovitz · 2023 [cited by examiner]
US 11882643B2 · Suslov · 2024 [cited by examiner]
US 12023081B2 · Suslov · 2024 [cited by applicant]
US 12058801B2 · Suslov · 2024 [cited by examiner]
US 20010021422A1 · Yamakoshi · 2001 [cited by examiner]
US 20010041227A1 · Hislop · 2001 [cited by applicant]
US 20020013583A1 · Camran et al. · 2002 [cited by applicant]
US 20020071906A1 · Rusch · 2002 [cited by applicant]
US 20020091385A1 · Paton et al. · 2002 [cited by applicant]
US 20020097767A1 · Krasnov · 2002 [cited by applicant]
US 20030030014A1 · Wieland et al. · 2003 [cited by applicant]
US 20030040744A1 · Latterell et al. · 2003 [cited by applicant]
US 20030075618A1 · Shimazu · 2003 [cited by applicant]
US 20030114845A1 · Paton et al. · 2003 [cited by applicant]
US 20030125728A1 · Nezhat et al. · 2003 [cited by applicant]
US 20030178511A1 · Dolatabadi et al. · 2003 [cited by applicant]
US 20030190414A1 · Van Steenkiste · 2003 [cited by applicant]
US 20040018317A1 · Heinrich et al. · 2004 [cited by applicant]
US 20040064139A1 · Yossepowitch · 2004 [cited by applicant]
US 20040068304A1 · Paton et al. · 2004 [cited by applicant]
US 20040116918A1 · Konesky · 2004 [cited by applicant]
US 20040124256A1 · Itsukaichi et al. · 2004 [cited by applicant]
US 20040129222A1 · Nylen et al. · 2004 [cited by applicant]
US 20040195219A1 · Conway et al. · 2004 [cited by applicant]
US 20040200417A1 · Hanawa · 2004 [cited by examiner]
US 20050082395A1 · Gardega · 2005 [cited by applicant]
US 20050120957A1 · Kowalsky et al. · 2005 [cited by applicant]
US 20050192610A1 · Houser et al. · 2005 [cited by applicant]
US 20050192611A1 · Houser · 2005 [cited by applicant]
US 20050192612A1 · Houser et al. · 2005 [cited by applicant]
US 20050234447A1 · Paton et al. · 2005 [cited by applicant]
US 20050255255A1 · Kawamura · 2005 [cited by examiner]
US 20050255419A1 · Belashchenko et al. · 2005 [cited by applicant]
US 20060004354A1 · Suslov · 2006 [cited by applicant]
US 20060037533A1 · Belashchenko et al. · 2006 [cited by applicant]
US 20060049149A1 · Shimazu · 2006 [cited by applicant]
US 20060090699A1 · Muller · 2006 [cited by applicant]
US 20060091116A1 · Suslov · 2006 [cited by applicant]
US 20060091117A1 · Blankenship et al. · 2006 [cited by applicant]
US 20060091119A1 · Zajchowski et al. · 2006 [cited by applicant]
US 20060108332A1 · Belashchenko · 2006 [cited by applicant]
US 20060124613A1 · Kumar · 2006 [cited by examiner]
US 20060189976A1 · Karni et al. · 2006 [cited by applicant]
US 20060217706A1 · Lau et al. · 2006 [cited by applicant]
US 20060266735A1 · Shannon · 2006 [cited by examiner]
US 20060287651A1 · Bayat · 2006 [cited by applicant]
US 20070021747A1 · Suslov · 2007 [cited by examiner]
US 20070021748A1 · Suslov · 2007 [cited by applicant]
US 20070029292A1 · Suslov et al. · 2007 [cited by applicant]
US 20070038214A1 · Morley et al. · 2007 [cited by applicant]
US 20070138147A1 · Molz et al. · 2007 [cited by applicant]
US 20070173871A1 · Houser et al. · 2007 [cited by applicant]
US 20070173872A1 · Neuenfeldt · 2007 [cited by applicant]
US 20070191828A1 · Houser et al. · 2007 [cited by applicant]
US 20080015566A1 · Livneh · 2008 [cited by applicant]
US 20080071206A1 · Peters · 2008 [cited by applicant]
US 20080114352A1 · Long et al. · 2008 [cited by applicant]
US 20080185366A1 · Suslov · 2008 [cited by applicant]
US 20080233669A1 · Hirakata · 2008 [cited by examiner]
US 20080246385A1 · Schamiloglu et al. · 2008 [cited by applicant]
US 20090039789A1 · Nikolay · 2009 [cited by applicant]
US 20090039790A1 · Suslov · 2009 [cited by applicant]
US 20100089742A1 · Suslov · 2010 [cited by applicant]
US 20110190752A1 · Suslov · 2011 [cited by applicant]
US 20110203543A1 · Agneray · 2011 [cited by examiner]
US 20110240460A1 · Begounov · 2011 [cited by examiner]
US 20120022522A1 · Suslov · 2012 [cited by applicant]
US 20130178004A1 · Hirakata · 2013 [cited by examiner]
US 20130313227A1 · Katagiri · 2013 [cited by examiner]
US 20140345802A1 · Umehara · 2014 [cited by examiner]
US 20140377966A1 · Funk · 2014 [cited by examiner]
US 20150126046A1 · Funk · 2015 [cited by examiner]
US 20150327906A1 · Suslov · 2015 [cited by examiner]
US 20150371876A1 · Terauchi · 2015 [cited by examiner]
US 20160008051A1 · Suslov · 2016 [cited by examiner]
US 20160051311A1 · Suslov · 2016 [cited by examiner]
US 20160081176A1 · Griffin · 2016 [cited by examiner]
US 20170339775A1 · Cheung · 2017 [cited by examiner]
US 20180168022A1 · Suslov · 2018 [cited by examiner]
US 20190148113A1 · Zhao · 2019 [cited by examiner]
US 20200253660A1 · Suslov · 2020 [cited by examiner]
US 20210118649A1 · Huh · 2021 [cited by examiner]
US 20210373054A1 · Fisk, II · 2021 [cited by examiner]
US 20210407771A1 · Funk · 2021 [cited by examiner]
US 20220102116A1 · Huh · 2022 [cited by examiner]
US 20230225041A1 · Suslov · 2023 [cited by examiner]
US 20240147599A1 · Suslov · 2024 [cited by examiner]
US 20240292512A1 · Raymond · 2024 [cited by examiner]
US 20250143771A1 · Suslov · 2025 [cited by applicant]
US 20250159791A1 · Suslov · 2025 [cited by examiner]
AU 2000250426B2 · 2005 [cited by applicant]
AU 2006252145A1 · 2007 [cited by applicant]
CA 983586A · 1976 [cited by applicant]
CA 1144104A · 1983 [cited by applicant]
CA 1308772C · 1992 [cited by applicant]
CA 2594515A1 · 2006 [cited by applicant]
CN 85107499B · 1987 [cited by applicant]
CN 1331836A · 2002 [cited by applicant]
CN 1557731A · 2004 [cited by applicant]
CN 1682578A · 2005 [cited by applicant]
DE 2033072A1 · 1971 [cited by applicant]
DE 4209005A1 · 1993 [cited by applicant]
DE 10127261A1 · 2002 [cited by applicant]
DE 102007040434A1 · 2009 [cited by applicant]
EP 0282677A1 · 1988 [cited by applicant]
EP 0411170A1 · 1991 [cited by applicant]
EP 0748149A1 · 1996 [cited by applicant]
EP 0851040A1 · 1998 [cited by applicant]
EP 1293169A1 · 2003 [cited by applicant]
EP 1570798A2 · 2005 [cited by applicant]
ES 2026344A6 · 1992 [cited by applicant]
FR 2193299A1 · 1974 [cited by applicant]
FR 2567747A1 · 1986 [cited by applicant]
GB 751735A · 1956 [cited by applicant]
GB 921016A · 1963 [cited by applicant]
GB 1125806A · 1968 [cited by applicant]
GB 1176333A · 1970 [cited by applicant]
GB 1268843A · 1972 [cited by applicant]
GB 2407050A · 2005 [cited by applicant]
GB 2579835A · 2020 [cited by examiner]
JP S479252A · 1972 [cited by applicant]
JP S52117255A · 1977 [cited by applicant]
JP S54120545U · 1979 [cited by applicant]
JP 57001580A · 1982 [cited by applicant]
JP 57068269A · 1982 [cited by applicant]
JP S6113600A · 1986 [cited by applicant]
JP S61193783A · 1986 [cited by applicant]
JP S61286075A · 1986 [cited by applicant]
JP S62123004A · 1987 [cited by applicant]
JP H01198539A · 1989 [cited by applicant]
JP H01319297A · 1989 [cited by applicant]
JP 3043678A · 1991 [cited by applicant]
JP H06262367A · 1994 [cited by applicant]
JP H09299380A · 1997 [cited by applicant]
JP H1024050A · 1998 [cited by applicant]
JP H10504751A · 1998 [cited by applicant]
JP H10234744A · 1998 [cited by applicant]
JP 2002541902A · 2002 [cited by applicant]
JP 2008036001A · 2008 [cited by applicant]
JP 2008284580A · 2008 [cited by applicant]
JP 2009541902A · 2009 [cited by applicant]
MX PA04010281A · 2005 [cited by applicant]
RU 2178684C2 · 2002 [cited by applicant]
RU 2183480C2 · 2002 [cited by applicant]
RU 2183946C2 · 2002 [cited by applicant]
WO WO9007395A1 · 1990 [cited by applicant]
WO WO9219166A1 · 1992 [cited by applicant]
WO WO9606572A1 · 1996 [cited by applicant]
WO WO9711647A1 · 1997 [cited by applicant]
WO WO0162169A2 · 2001 [cited by applicant]
WO WO0230308A1 · 2002 [cited by applicant]
WO WO03028805A1 · 2003 [cited by applicant]
WO WO2004028221A1 · 2004 [cited by applicant]
WO WO2004030551A1 · 2004 [cited by applicant]
WO WO2004105450A1 · 2004 [cited by applicant]
WO WO2005099595A1 · 2005 [cited by applicant]
WO WO2006012165A2 · 2006 [cited by applicant]
WO WO2007003157A2 · 2007 [cited by applicant]
WO WO2007006516A2 · 2007 [cited by applicant]
WO WO2007006517A2 · 2007 [cited by applicant]
WO WO2007040702A2 · 2007 [cited by applicant]
WO WO2009018837A1 · 2009 [cited by applicant]
WO WO2012010207A1 · 2012 [cited by applicant]
WO WO2022047227A2 · 2022 [cited by examiner]
510(k) Notification (21 CFR 807.90(e)) for the Plasma Surgical Ltd. PlasmaJet® Neutral Plasma Surgery System, Section 10—Executive Summary, dated Jan. 25, 2008—K080197, 2 pages. [cited by applicant]
510(k) Summary, Plasma Surgical Ltd., dated Jun. 2, 2008, 3 pages. [cited by applicant]
510(k) Summary, Plasma Surgical Ltd., dated Oct. 30, 2003, 2 pages. [cited by applicant]
Aptekman, 2007, “Spectroscopic analysis of the PlasmaJet® argon plasma with 5 mm-0.5 coag-cut handpieces,” Document PSSRP-106—K080197, 14 pages. [cited by applicant]
Asawanonda et al., “308-nm excimer laser for the treatment of psoriasis: a dose-response study”, Arch Dermatol. May 2000; 136(5): 619-24. [cited by applicant]
Branson, M. D., 2005, “Preliminary experience with neutral plasma, a new coagulation technology, in plastic surgery,” Fayetteville, NY, 2 pages. [cited by applicant]
Canadian Office Action for Application No. 2,695,650, dated Jun. 18, 2013, 3 pages. [cited by applicant]
Canadian Office Action for Application No. 2,695,902, dated Jun. 12, 2013, 2 pages. [cited by applicant]
Charpentier et al., 2008, “Multicentric medical registry on the use of the Plasma Surgical PlasmaJet® System in thoracic surgery,” Club Thorax, 3 pages. [cited by applicant]
Chen et al., “What do we know about long laminar plasma jets?”, Pure Appl Chem, Jun. 2006, 78(6): 1253-1264. [cited by applicant]
Cheng et al., “Comparison of laminar and turbulent thermal plasma jet characteristics—a modeling study”, Jun. 2006, Plasma Chemistry and Plasma Processing 26(3): 211-235. [cited by applicant]
Chinese Office Action for Application No. 200780052471.5, dated Dec. 5, 2012, 7 pages. [cited by applicant]
Chinese Office Action for Application No. 200780052471.5, dated May 25, 2012, 13 pages. [cited by applicant]
Chinese Office Action for Application No. 200780100857.9, dated May 25, 2012, 17 pages. [cited by applicant]
Chinese Office Action for Application No. 200780100857.9, dated May 30, 2013, 18 pages. [cited by applicant]
Chinese Office Action for Application No. 200780100858.3, dated Apr. 27, 2012, 10 pages. [cited by applicant]
Chinese Office Action for Application No. 200780100857.9, dated Nov. 28, 2011, 17 pages. [cited by applicant]
Chinese Office Action of application No. 200780100858.3, dated Aug. 29, 2012, 6 pages. [cited by applicant]
Chinese Office Action of application No. 2007801008583, dated Oct. 19, 2011,10 pages. [cited by applicant]
Chinese Office Action of Chinese Appl. No. 2012220800745680, dated Nov. 13, 2012, 16 pages. [cited by applicant]
Chinese Office Action for Chinese Application No. 200680030194.3, dated Jan. 31, 2011, 9 pages. [cited by applicant]
Chinese Office Action for Chinese Application No. 200680030216.6, dated Oct. 26, 2010, 8 pages. [cited by applicant]
Chinese Office Action for Chinese Application No. 200680030225.5, dated Jun. 11, 2010, 9 pages. [cited by applicant]
Chinese Office Action of application No. 200680030225.5, dated Mar. 9, 2011, 6 pages. [cited by applicant]
CoagSafe™ Neutral Plasma Coagulator Operator Manual, Part No. OMC-2100-1, Revision 1.1, dated Mar. 2003—Appendix 1 of K030819, 22 pages. [cited by applicant]
Coven et al., “PUVA-induced lymphocyte apoptosis: mechanism of action in psoriasis”, Feb. 1999, Photodermatol Photoimmunol Photomed. 15(1): 22-7. [cited by applicant]
Dabringhausen et al., “Determination of HID electrode falls in a model lamp I”, Jul. 2002, Journal of Physics D Applied Physics 35(14):1621-1630. [cited by applicant]
Davis (Ed.), 2004, ASM thermal Spray society, Handbook of Thermal Spray Technology, U.S., 131 pages. [cited by applicant]
Deb et al., “Histological quantification of the tissue damage caused in vivo y neutral PlasmaJet™ Coagulator”, Nottingham University Hospitals, Queen's Medical Centre, Nottingham NG7 2UH—Poster, dated Oct. 2009, 1 page. [cited by applicant]
Electrosurgical Generators Force FX™ Electrosurgical Generators by ValleyLab—K080197, dated Sep. 2002, 4 pages. [cited by applicant]
ERBE APC 300 Argon Plasma Coagulation Unit for Endoscopic Applications, Brochure 1997—Appendix 4 of K030819, 7 pages. [cited by applicant]
European Office Action for European Application No. EP 07786583.0-1226, dated Jun. 29, 2010, 7 pages. [cited by applicant]
European Office Action of Appl. No. 07786 582.2-1551, dated Mar. 11, 2015, 6 pages. [cited by applicant]
European Office Action of Appl. No. 10/ 734 147.1-1551, dated Oct. 28, 2015, 4 pages. [cited by applicant]
Examiner's Answer to Applicant's Appeal Brief in U.S. Appl. No. 11/482,580, dated Jun. 18, 2013, 10 pages. [cited by applicant]
Extended European Search Report mailed Aug. 8, 2017 for European Application No. EP 16 20 3010, 5 pages. [cited by applicant]
Extended European Search Report mailed Oct. 2, 2019 for European Application No. EP 19175795.4, 2 pages. [cited by applicant]
Feldman et al., “Efficacy of the 308-nm excimer laser for treatment of psoriasis: results of a multicenter study,” J Am Acad Dermatol. Jun. 2002; 46(6): 900-6. [cited by applicant]
Final Office Action for U.S. Appl. No. 12/696,411, dated Jun. 10, 2013, 12 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 16/599,532 dated Aug. 16, 2023, 11 pages. [cited by applicant]
Final Office Action mailed Jan. 16, 2015 for U.S. Appl. No. 12/841,361, 11 pages. [cited by applicant]
Final Office Action mailed May 3, 2019 for U.S. Appl. No. 14/810,032, 6 pages. [cited by applicant]
Force Argon TM II System, Improved precision and control in electrosurgery, by Valleylab, 2006—K080197, 2 pages. [cited by applicant]
Gerber et al., “Ultraviolet B 308-nm excimer laser treatment of psoriasis: a new phototherapeutic approach,” Dec. 2003, Br. J. Dermatol., 149:12580-1258. [cited by applicant]
Gugenheim et al., 2006, “Open, multicentric, clinical evaluation of the technical efficacy, reliability, safety, and clinical tolerance of the plasma surgical PlasmaJet™ system for intra-operative coagulation in open an… [cited by applicant]
Haemmerich et al., 2003, “Hepatic radiofrequency ablation with internally cooled probes: effect of coolant temperature on lesion size,” IEEE Transactions of Biomedical Engineering, 50(4):493-500. [cited by applicant]
Haines et al., “Argon neutral plasma energy for laparoscopy and open surgery recommended power settings and applications,” Royal Surrey county Hospital, Guildford, Surry, UK. Dated Oct. 2009, 1 page. [cited by applicant]
Honigsman, 2001, “Phototherapy for psoriasis,” Clin. Exp. Dermatol, 26:343-350. [cited by applicant]
Huang et al., 2008, “Laminar/turbulent plasma jets generated at reduced pressure,” IEEE Transaction on Plasma Science, 36(4):1052-1053. [cited by applicant]
Iannelli et al., 2005, “Neutral plasma coagulation (NPC)—A preliminary report on a new technique for post-bariatric corrective abdominoplasty,” Department of Digestive Surgery, University Hospital, Nice, France, 1 page. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/EP2007/006939, dated Feb. 9, 2010, 8 pages. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/EP2007/006940, dated Feb. 9, 2010, 7 pages. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/US2021/048052 dated Feb. 28, 2023, 11 pages. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2021/048052, mailed Feb. 28, 2022, 18 pages. [cited by applicant]
International Search Report for International Application No. PCT/EP2010/060641, dated Apr. 14, 2011, 5 pages. [cited by applicant]
International Search Report of International application No. PCT/EP2010/051130, dated Sep. 27, 2010, 7 pages. [cited by applicant]